Targeted Drug for Advanced Pancreatic Cancer Sparks Early Enthusiasm

By News Health
3 weeks Ago

(MedPage Today) — SAN FRANCISCO — Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease control with a novel KRAS G12D inhibitor, a small preliminary study showed.
The early results showed that…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119372

Author :

Publish date : 2026-01-10 14:01:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

How Kids' Neuro Outcomes Compare After Forceps, Vacuum, or Second-Stage C-Section

Aortic Stenosis Mortality Increased After Broad FDA Approval of TAVR

Study Finds Surprising Link Between Aspirin in Seniors and Cancer Mortality

U.S. Has No Backup Plan if Foreign Generic Drugmakers Bow Out, Senator Says

TrumpRx May Not Be Legal in Its Current Form, Senators Contend

High-Deductible Health Plans and Cancer a Bad Mix